Company:  ALNYLAM PHARMACEUTICALS, ... (ALNY)
Form Type:  SC 13G/A
Filing Date:  2/12/2020 
CIK:  0001178670 
Address:  675 WEST KENDALL STREET
HENRI A. TERMEER SQUARE
 
City, State, Zip:  CAMBRIDGE, Massachusetts 02142 
Telephone:  (617) 551-8200 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$128.17  
Change: 
-3.735 (-2.83%)  
Trade Time: 
03:10 PM EST  
Market Cap: 
$14.72B
Trade ALNY now with 

© 2020  
Description of Business
Alnylam Pharmaceuticals, Inc. (also referred to as Alnylam, we, our or us) is a global commercial-stage biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for sequence-specific silencing and regulation of gene expression. By harnessing the RNAi pathway, we have developed a new class of innovative medicines, known as RNAi therapeutics. RNAi therapeutics are comprised of small interfering RNA, or siRNA, and function upstream of conventional medicines by potently silencing messenger RNA, or mRNA, that encode for proteins implicated in causing disease, thus preventing them from being made. We believe this is a revolutionary approach with the potential to transform the care of patients with genetic and other diseases.
Register and access this filing in:     
  FORM SC 13G/A